• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

低热量饮食可增强外源性心房利钠肽对肥胖高血压患者的肾脏、血流动力学及体液效应。

Low calorie diet enhances renal, hemodynamic, and humoral effects of exogenous atrial natriuretic peptide in obese hypertensives.

作者信息

Dessì-Fulgheri P, Sarzani R, Serenelli M, Tamburrini P, Spagnolo D, Giantomassi L, Espinosa E, Rappelli A

机构信息

Istituto di Medicina Clinica, Cattedra di Medicina Interna I, University of Ancona, Ancona, Italy.

出版信息

Hypertension. 1999 Feb;33(2):658-62. doi: 10.1161/01.hyp.33.2.658.

DOI:10.1161/01.hyp.33.2.658
PMID:10024323
Abstract

The expression of the natriuretic peptide clearance receptor is abundant in human and rat adipose tissue, where it is specifically inhibited by fasting. In obese hypertensives, plasma atrial natriuretic peptide (ANP) levels were found to be lower than in obese normotensives. Therefore, the increased adipose mass might influence ANP levels and/or its biological activity. The aim of the present study was to evaluate whether the humoral, hemodynamic, and renal effects of exogenous ANP in obese hypertensives might be enhanced by a very low calorie diet. Eight obese hypertensives received a bolus injection of ANP (0.6 mg/kg) after 2 weeks of a normal calorie/normal sodium diet, and blood pressure (BP), heart rate, ANP, cGMP, plasma renin activity, and aldosterone were evaluated for 2 hours before and after the injection. Diuresis and natriuresis were measured every 30 minutes. The patients then started a low calorie/normal sodium diet (510 kcal/150 mmol/d) for 4 days, and then the ANP injection protocol was repeated. The low calorie diet induced a slight weight loss (from 90.6+/-1.1 to 87. 7+/-1.2 kg; P<0.01), which was accompanied by increase of cGMP excretion (from 146.0+/-10.1 to 154.5+/-9.5 nmol/24 h; P<0.05) together with a reduction of BP (P<0.01 versus basal levels). ANP injection after diet was followed by an increase of ANP levels similar to that observed before diet, but plasma cGMP, diuresis, and natriuresis increased significantly only after diet. Similarly, the decrease of BP after ANP administration was significantly higher after diet (change in mean arterial pressure, -6.4+/-0.7 versus -4. 0+/-0.6 mm Hg; P<0.05) as well as that of aldosterone (P<0.01). These data show that a low calorie diet enhances the humoral, renal, and hemodynamic effects of ANP in obese hypertensives and confirm the importance of caloric intake in modulating the biological activity of ANP, suggesting that the natriuretic peptide system can play a role in the acute changes of natriuresis and diuresis associated with caloric restriction.

摘要

利钠肽清除受体在人和大鼠脂肪组织中表达丰富,禁食可特异性抑制其表达。在肥胖高血压患者中,发现血浆心房利钠肽(ANP)水平低于肥胖血压正常者。因此,增加的脂肪量可能会影响ANP水平和/或其生物活性。本研究的目的是评估极低热量饮食是否能增强外源性ANP对肥胖高血压患者的体液、血流动力学和肾脏效应。8名肥胖高血压患者在接受正常热量/正常钠饮食2周后,静脉注射一剂ANP(0.6 mg/kg),并在注射前后2小时评估血压(BP)、心率、ANP、环磷酸鸟苷(cGMP)、血浆肾素活性和醛固酮水平。每30分钟测量一次尿量和尿钠排泄量。然后患者开始低热量/正常钠饮食(510千卡/150毫摩尔/天),持续4天,之后重复ANP注射方案。低热量饮食导致体重略有下降(从90.6±1.1千克降至87.7±1.2千克;P<0.01),同时cGMP排泄量增加(从146.0±10.1纳摩尔/24小时增至154.5±9.5纳摩尔/24小时;P<0.05),血压降低(与基础水平相比,P<0.01)。饮食后注射ANP后,ANP水平升高幅度与饮食前相似,但血浆cGMP、尿量和尿钠排泄量仅在饮食后显著增加。同样,饮食后ANP给药后血压下降幅度显著更大(平均动脉压变化,-6.4±0.7与-4.0±0.6毫米汞柱;P<0.05),醛固酮下降幅度也更大(P<0.01)。这些数据表明,低热量饮食可增强外源性ANP对肥胖高血压患者的体液、肾脏和血流动力学效应,并证实热量摄入在调节ANP生物活性中的重要性,提示利钠肽系统可能在与热量限制相关的尿钠排泄和利尿的急性变化中发挥作用。

相似文献

1
Low calorie diet enhances renal, hemodynamic, and humoral effects of exogenous atrial natriuretic peptide in obese hypertensives.低热量饮食可增强外源性心房利钠肽对肥胖高血压患者的肾脏、血流动力学及体液效应。
Hypertension. 1999 Feb;33(2):658-62. doi: 10.1161/01.hyp.33.2.658.
2
The natriuretic peptide system in obesity-related hypertension: new pathophysiological aspects.肥胖相关性高血压中的利钠肽系统:新的病理生理学方面
J Nephrol. 1998 Nov-Dec;11(6):296-9.
3
Plasma atrial natriuretic peptide and natriuretic peptide receptor gene expression in adipose tissue of normotensive and hypertensive obese patients.正常血压和高血压肥胖患者脂肪组织中血浆心房利钠肽及利钠肽受体基因表达
J Hypertens. 1997 Dec;15(12 Pt 2):1695-9. doi: 10.1097/00004872-199715120-00074.
4
Pressure-dependent, enhanced natriuretic response to low-dose, atrial natriuretic peptide infusion in essential hypertension.在原发性高血压中,对低剂量心房利钠肽输注的压力依赖性利钠反应增强。
J Intern Med. 1994 Dec;236(6):665-74. doi: 10.1111/j.1365-2796.1994.tb00860.x.
5
[The effects of the acute administration of atrial natriuretic peptide on the mechanisms regulating diuresis and natriuresis in the essential hypertension patient].[急性给予心房利钠肽对原发性高血压患者利尿和利钠调节机制的影响]
Ann Ital Med Int. 1991 Jul-Sep;6(3):273-83.
6
The role of atrial natriuretic peptide in natriuresis of fasting.
J Hypertens. 1992 Sep;10(9):1041-4.
7
Natriuretic peptide analogues with distinct vasodilatory or renal activity: integrated effects in health and experimental heart failure.具有不同血管舒张或肾脏活性的利钠肽类似物:在健康和实验性心力衰竭中的综合作用。
Cardiovasc Res. 2021 Jan 21;117(2):508-519. doi: 10.1093/cvr/cvaa052.
8
Dose-response study of atrial natriuretic peptide bolus injection in healthy man.健康男性静脉注射心房利钠肽的剂量反应研究。
Eur J Clin Invest. 1993 Jan;23(1):37-45. doi: 10.1111/j.1365-2362.1993.tb00715.x.
9
Clearance receptors and endopeptidase: equal role in natriuretic peptide metabolism in heart failure.清除受体和内肽酶:在心力衰竭中利钠肽代谢中发挥同等作用。
Am J Physiol. 1997 Nov;273(5):H2372-9. doi: 10.1152/ajpheart.1997.273.5.H2372.
10
Effect of atrial natriuretic peptide (8-33-Met ANP) in patients with hypertension.
Am J Hypertens. 1992 May;5(5 Pt 1):266-75. doi: 10.1093/ajh/5.5.266.

引用本文的文献

1
Health Benefits of Intermittent Fasting.间歇性禁食的健康益处。
Microb Physiol. 2024;34(1):142-152. doi: 10.1159/000540068. Epub 2024 Jul 2.
2
Adipocentric origin of the common cardiometabolic complications of obesity in the young up to the very old: pathophysiology and new therapeutic opportunities.从青年到老年肥胖常见心脏代谢并发症的脂肪中心起源:病理生理学与新的治疗机遇
Front Med (Lausanne). 2024 Apr 8;11:1365183. doi: 10.3389/fmed.2024.1365183. eCollection 2024.
3
Natriuretic Peptide Clearance Receptor (NPR-C) Pathway as a Novel Therapeutic Target in Obesity-Related Heart Failure With Preserved Ejection Fraction (HFpEF).
利钠肽清除受体(NPR-C)通路作为射血分数保留的肥胖相关性心力衰竭(HFpEF)的新型治疗靶点
Front Physiol. 2021 May 21;12:674254. doi: 10.3389/fphys.2021.674254. eCollection 2021.
4
Blood Pressure Changes in 1610 Subjects With and Without Antihypertensive Medication During Long-Term Fasting.1610 例接受和不接受抗高血压药物治疗的受试者在长期禁食期间的血压变化。
J Am Heart Assoc. 2020 Dec;9(23):e018649. doi: 10.1161/JAHA.120.018649. Epub 2020 Nov 23.
5
The Importance of Natriuretic Peptides in Cardiometabolic Diseases.利钠肽在心脏代谢疾病中的重要性。
J Endocr Soc. 2020 May 15;4(6):bvaa052. doi: 10.1210/jendso/bvaa052. eCollection 2020 Jun 1.
6
Natriuretic peptides promote glucose uptake in a cGMP-dependent manner in human adipocytes.利钠肽以 cGMP 依赖的方式促进人脂肪细胞的葡萄糖摄取。
Sci Rep. 2018 Jan 18;8(1):1097. doi: 10.1038/s41598-018-19619-0.
7
Cardiac Natriuretic Peptides, Hypertension and Cardiovascular Risk.心脏利钠肽、高血压与心血管风险
High Blood Press Cardiovasc Prev. 2017 Jun;24(2):115-126. doi: 10.1007/s40292-017-0196-1. Epub 2017 Apr 4.
8
Cardiometabolic crosstalk in obesity-associated arterial hypertension.肥胖相关动脉高血压中心血管代谢串扰。
Rev Endocr Metab Disord. 2016 Mar;17(1):19-28. doi: 10.1007/s11154-016-9348-1.
9
Hypertensive heart disease and obesity: a complex interaction between hemodynamic and not hemodynamic factors.高血压性心脏病与肥胖:血流动力学和非血流动力学因素之间的复杂相互作用。
High Blood Press Cardiovasc Prev. 2014 Jun;21(2):81-7. doi: 10.1007/s40292-014-0054-3. Epub 2014 May 13.
10
Childhood obesity: a life-long health risk.儿童肥胖:终身健康风险。
Acta Pharmacol Sin. 2012 Feb;33(2):189-93. doi: 10.1038/aps.2011.204.